Lu K - Search Results

1

Poor therapeutic outcomes in KRAS-mutant non-small cell lung cancer due to chemoresistance conferred by SLC7A11.

Zhang S, Ge Y, Liu J, Lu K. Zhang S, et al. Among authors: lu k. Clin Transl Oncol. 2024 Jul 26. doi: 10.1007/s12094-024-03592-4. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39060774

2

Therapeutic Advances of Rare ALK Fusions in Non-Small Cell Lung Cancer.

Xiang Y, Zhang S, Fang X, Jiang Y, Fang T, Liu J, Lu K. Xiang Y, et al. Among authors: lu k. Curr Oncol. 2022 Oct 16;29(10):7816-7831. doi: 10.3390/curroncol29100618. Curr Oncol. 2022. PMID: 36290895 Free PMC article. Review.

3

Real world experience with camrelizumab in patients with advanced non-small cell lung cancer: a prospective multicenter cohort study (NOAH-LC-101).

Wang R, Shi M, Ji M, Han Z, Chen L, Liu Y, Lu K, Liu L, Chen B, Zhang X, Miao L, Shu Y. Wang R, et al. Among authors: lu k. Transl Lung Cancer Res. 2023 Apr 28;12(4):786-796. doi: 10.21037/tlcr-23-121. Epub 2023 Apr 25. Transl Lung Cancer Res. 2023. PMID: 37197631 Free PMC article.

4

Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review.

Jiang Y, Fang X, Xiang Y, Fang T, Liu J, Lu K. Jiang Y, et al. Among authors: lu k. Curr Oncol. 2023 May 28;30(6):5337-5349. doi: 10.3390/curroncol30060405. Curr Oncol. 2023. PMID: 37366888 Free PMC article. Review.

5

Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study.

Fang X, Xiang Y, Lu K. Fang X, et al. Among authors: lu k. Front Oncol. 2023 Sep 11;13:1248690. doi: 10.3389/fonc.2023.1248690. eCollection 2023. Front Oncol. 2023. PMID: 37752994 Free PMC article.

6

Advances in the Diagnosis and Treatment of Advanced Non-Small-Cell Lung Cancer With EGFR Exon 20 Insertion Mutation.

Liu J, Xiang Y, Fang T, Zeng L, Sun A, Lin Y, Lu K. Liu J, et al. Among authors: lu k. Clin Lung Cancer. 2024 Mar;25(2):100-108. doi: 10.1016/j.cllc.2023.11.010. Epub 2023 Nov 23. Clin Lung Cancer. 2024. PMID: 38172024 Review.

7

MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5.

Liu XH, Lu KH, Wang KM, Sun M, Zhang EB, Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, De W, Wang ZX. Liu XH, et al. BMC Cancer. 2012 Aug 9;12:348. doi: 10.1186/1471-2407-12-348. BMC Cancer. 2012. PMID: 22876840 Free PMC article.

8

MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

Liu J, Lu KH, Liu ZL, Sun M, De W, Wang ZX. Liu J, et al. BMC Cancer. 2012 Nov 14;12:519. doi: 10.1186/1471-2407-12-519. BMC Cancer. 2012. PMID: 23151088 Free PMC article.

9

Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion.

Nie FQ, Zhu Q, Xu TP, Zou YF, Xie M, Sun M, Xia R, Lu KH. Nie FQ, et al. Tumour Biol. 2014 Aug;35(8):7587-94. doi: 10.1007/s13277-014-2009-7. Epub 2014 May 4. Tumour Biol. 2014. PMID: 24793017

10

Icotinib is an active treatment of non-small-cell lung cancer: a retrospective study.

Chen X, Zhu Q, Liu Y, Liu P, Yin Y, Guo R, Lu K, Gu Y, Liu L, Wang J, Wang Z, Røe OD, Shu Y, Zhu L. Chen X, et al. Among authors: lu k. PLoS One. 2014 May 16;9(5):e95897. doi: 10.1371/journal.pone.0095897. eCollection 2014. PLoS One. 2014. PMID: 24836053 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,011 results

Search Page

Filters